Dissection of the FCGR3A association with RA: Increased association in men and with autoantibody positive disease

Annals of the Rheumatic Diseases

Volumn 69, Issue 6, 2010, Pages 1054-1057

  Robinson, James I ^a   Barrett, Jennifer H ^a   Taylor, John C ^a   Naven, Marc ^a   Corscadden, Diane ^a   Barton, Anne ^b   Wilson, Anthony G ^c   Emery, Paul ^a   Isaacs, John D ^d   Morgan, Ann W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; FC GAMMA RECEPTOR IIIA; FC RECEPTOR; HLA DR ANTIGEN; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; UNITED KINGDOM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RECEPTORS, IGG; RHEUMATOID FACTOR; SEX FACTORS; YOUNG ADULT;

EID: 77953706148     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.110874     Document Type: Article

References (24)

1. Gregersen PK, Behrens TW. Genetics of autoimmune diseases - disorders of immune homeostasis. Nat Rev Genet 2006;7:917-28.
2. She X, Cheng Z, Zöllner S, et al. Mouse segmental duplication and copy number variation. Nat Genet 2008;40:909-14.
3. Hughes AL. Gene duplication and recombination in the evolution of mammalian Fc receptors. J Mol Evol 1996;43:4-10.
4. Koene HR, Kleijer M, Algra J, et al. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 1997;90:1109-14.
5. Alizadeh BZ, Valdigem G, Coenen MJ, et al. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. Hum Mol Genet 2007;16:2552-9.
6. Thabet MM, Huizinga TW, Marques RB, et al. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2009;68:1775-80.
7. Kastbom A, Ahmadi A, Söderkvist P, et al. The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project). Rheumatology (Oxford) 2005;44:1294-8.
8. Morgan AW, Griffiths B, Ponchel F, et al. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000;43:2328-34.
9. Morgan AW, Keyte VH, Babbage SJ, et al. FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study. Rheumatology (Oxford) 2003;42:528-33.
10. Morgan AW, Barrett JH, Griffiths B, et al. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther 2006;8:R5.
11. Brun JG, Madland TM, Vedeler CA. Immunoglobulin G fc-receptor (FcgammaR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. J Rheumatol 2002;29:1135-40.
12. Nieto A, Cáliz R, Pascual M, et al. Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 2000;43:735-9.
13. Milicic A, Brown MA, Wordsworth BP. The FcγRIIIa 158F/V variant does not predispose to RA. Rheumatology (Oxford) 2001;40(Suppl 1):15.
14. Milicic A, Misra R, Agrawal S, et al. The F158V polymorphism in FcgammaRIIIA shows disparate associations with rheumatoid arthritis in two genetically distinct populations. Ann Rheum Dis 2002;61:1021-3.
15. Kallberg H, Padyukov L, Plenge RM, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007;80:867-75.
16. Potter C, Hyrich KL, Tracey A, et al. Association of rheumatoid factor and anticyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Ann Rheum Dis 2009;68:69-74.
17. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Mewar D, Coote A, Moore DJ, et al. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006;8:R128.
19. Catto AJ, Carter AM, Stickland M, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 1997;77:730-4.
20. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
21. Morgan AW, Thomson W, Martin SG, et al. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 2009;60:2565-76.
22. Abrahams VM, Cambridge G, Lydyard PM, et al. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum 2000;43:608-16.
23. Kim PM, Lam HY, Urban AE, et al. Analysis of copy number variants and segmental duplications in the human genome: evidence for a change in the process of formation in recent evolutionary history. Genome Res 2008;18:1865-74.
24. Hollox EJ, Detering JC, Dehnugara T. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat 2009;30:477-84.